We are live on ! Find out more
BATRK icon

Atlanta Braves Holdings Series B

177 hedge funds and large institutions have $836M invested in Atlanta Braves Holdings Series B in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 34

1% more capital invested

Capital invested by funds: $832M → $836M (+$4.38M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

0.15% less ownership

Funds ownership: 75.06%74.92% (-0.15%)

3% less funds holding

Funds holding: 183177 (-6)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
177
Holders Change
-6
Holders Change %
-3.28%
% of All Funds
3.84%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
19
Increased
59
Reduced
34
Closed
22
Calls
$467K
Puts
Net Calls
+$467K
Net Calls Change
-$292K
Name Holding Trade Value Shares
Change
Change in
Stake
VDBMI
26
Van Den Berg Management I
Texas
$8.49M -$196K -7,162 -2%
Loomis, Sayles & Company
27
Loomis, Sayles & Company
Massachusetts
$7.65M +$1.42M +51,698 +23%
PGIM
28
Pacific Global Investment Management
California
$7.19M +$56.6K +2,063 +0.8%
Charles Schwab
29
Charles Schwab
California
$5.78M +$186K +6,775 +3%
AC
30
AWH Capital
Texas
$5.59M
HKAM
31
Horizon Kinetics Asset Management
New York
$5.48M -$139K -5,058 -3%
Norges Bank
32
Norges Bank
Norway
$5.46M -$795K -28,964 -13%
OCM
33
Oaktree Capital Management
California
$5.11M -$2.31M -84,100 -32%
UBS Group
34
UBS Group
Switzerland
$4.95M +$293K +10,696 +6%
RJA
35
Raymond James & Associates
Florida
$4.41M +$160K +5,831 +4%
CCPM
36
Cooper Creek Partners Management
New York
$4.25M +$3.02M +110,105 +264%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.81M -$78.7K -2,868 -2%
Two Sigma Investments
38
Two Sigma Investments
New York
$3.32M -$1.48M -54,124 -31%
AP
39
Archon Partners
New Jersey
$3.31M
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$3.28M +$1.87M +68,326 +139%
NFGCM
41
Norman Fields Gottscho Capital Management
New York
$3.17M +$11K +400 +0.4%
WIM
42
Weitz Investment Management
Nebraska
$2.94M
BM
43
Bislett Management
California
$2.8M
Morgan Stanley
44
Morgan Stanley
New York
$2.62M -$13.7M -498,037 -84%
SIC
45
Schwartz Investment Counsel
Michigan
$2.18M
Russell Investments Group
46
Russell Investments Group
United Kingdom
$2.15M +$268K +9,760 +15%
Deutsche Bank
47
Deutsche Bank
Germany
$2.03M -$5.76M -209,843 -74%
AC
48
Athanor Capital
New York
$1.98M -$1.03M -37,510 -35%
First Manhattan
49
First Manhattan
New York
$1.91M -$494 -18 -0%
ZIM
50
Zacks Investment Management
Illinois
$1.91M +$85.5K +3,115 +5%

BATRK Hedge Fund Activity: Q2 2019 in Review

177 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Atlanta Braves Holdings Series B (BATRK) for Q2 2019, worth a combined $836M — up 0.53% from $832M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BATRK and 19 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 59 added.

The largest buyer was Nuveen, opening a new position worth an estimated $10.6M. The largest seller was Morgan Stanley, cutting an estimated $13.7M.

  • 177 institutional investors held Atlanta Braves Holdings Series B (BATRK) as of Q2 2019, down from 183 in Q1 2019.
  • Funds reported $836M of Atlanta Braves Holdings Series B stock for Q2 2019, up 0.53% quarter-over-quarter.
  • 19 funds opened new Atlanta Braves Holdings Series B positions in Q2 2019 and 22 closed out, a net change of -3 holders.
  • The largest Atlanta Braves Holdings Series B buyer in Q2 2019 was Nuveen, an estimated $10.6M added.
  • The largest Atlanta Braves Holdings Series B seller in Q2 2019 was Morgan Stanley, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2019.